Serology

Hepatitis – Hepatitis B serology

Clinical material provided (Liquid Serum / Plasma – 1.5 mL) to assess the detection of Hepatitis B using serological markers

Frequency / Number of samples

6 surveys / 2 samples per survey

Tests

HBsAg-Screening, HBsAg-Supplementary, HBsAg-Confirmatory, Anti-HBs, Anti-HBc, Anti-HBc IgM, HBeAg, Anti-HBe, Hepatitis B Interpretation

Hepatitis – Hepatitis C serology

Clinical material provided (Liquid Serum / Plasma – 0.5 mL) to assess the detection of Hepatitis C using serological markers

Frequency / Number of samples

6 surveys / 2 samples per survey

Tests

HCV Ag, HCV Ag-Ab Assay, Anti-HCV-Screening, Anti-HCV-Supplementary, Anti-HCV-Confirmatory, Hepatitis C Interpretation

Hepatitis – Hepatitis D serology

Clinical material (Liquid Serum / Plasma – 0.5 mL) provided to assess the detection of Hepatitis D using serological markers

Frequency / Number of samples

1 survey / 2 samples per survey

Tests

Anti-HDV Total Antibody, Anti-HD IgM, HDAg-Screening, HDAg-Supplementary, HDAg-Confirmatory, Hepatitis D Interpretation

Hepatitis – Hepatitis E serology

Clinical material provided (Liquid Serum / Plasma – 0.3 mL) to assess the detection of Hepatitis E using serological markers

Frequency / Number of samples

1 survey / 2 samples per survey

Tests

Anti-HEV Total Antibody, Anti-HEV IgG, Anti-HEV IgM, Hepatitis E Interpretation

Infectious Mononucleosis

Clinical material provided (Liquid Serum / Plasma – 0.2 mL) to assess the detection of Infectious Mononucleosis

Frequency / Number of samples

6 surveys / 2 samples per survey

Tests

Infectious Mononucleosis ICT, Agglutination, Latex

Lymphadenopathy – Cytomegalovirus serology

Clinical material provided (Liquid Serum / Plasma – 0.6 mL) to assess the detection of Cytomegalovirus using serological markers

Frequency / Number of samples

4 surveys / 2 samples per survey

Tests

Cytomegalovirus IgG, Cytomegalovirus Total Antibody, Cytomegalovirus IgM Screening, Cytomegalovirus IgM Supplementary, Cytomegalovirus Confirmatory, Cytomegalovirus Avidity, CMV Interpretation

Lymphadenopathy – Epstein Barr Virus serology

Clinical material provided (Liquid Serum / Plasma – 0.6 mL) to assess the detection of Epstein Barr Virus using serological markers

Frequency / Number of samples

4 surveys / 2 samples per survey

Tests

EBV VCA IgG, EBV VCA IgM, EBV EBNA IgG, Heterophile Antibody, EBV EA IgG, EBV EBNA IgM, EBV Avidity, EBV EA and EBNA IgA, EBV EA IgA, EBV VCA IgA, EBV Interpretation

Lymphadenopathy – Toxoplasma serology

Clinical material provided (Liquid Serum / Plasma – 0.6 mL) to assess the detection of Toxoplasma using serological markers

Frequency / Number of samples

4 surveys / 2 samples per survey

Tests

Toxoplasmosis IgG, Toxoplasmosis Total Antibody, Toxoplasmosis IgM Screening, Toxoplasmosis IgM Supplementary, Toxoplasmosis IgA, Toxoplasmosis Avidity, Toxoplasmosis Interpretation

Molecular Infectious Diseases – Alphavirus & Flavivirus NAT

Simulated clinical material provided (Liquid Inactivated viral culture lysate – 0.25 mL) to assess the detection and identification of Alphaviruses and Flaviviruses using molecular assays

Frequency / Number of samples

2 surveys / 6 samples per survey

Tests

Alphavirus Group, Barmah Forest Virus, Chikungunya Virus, Ross River Virus, Sindbis Virus, Flavivirus Group, Dengue Virus, Japanese Encephalitis Virus, Kunjin Virus, Murray Valley Encephalitis Virus, Yellow Fever Virus, West Nile Virus, Zika Virus, Final Interpretation

Molecular Infectious Diseases – Gastrointestinal Viral Pathogens

Simulated clinical material provided (Liquid Inactivated viral culture lysate – 0.5 mL) to assess the detection of Gastrointestinal Viral Pathogens using molecular assays

Frequency / Number of samples

1 survey / 6 samples per survey

Tests

Gastrointestinal Viral Pathogens Multiplex Assays, Adenovirus, Astrovirus, Norovirus, Rotavirus, Sapovirus, Final Interpretation

Molecular Infectious Diseases – Hepatitis B DNA (Qualitative/ Quantitative)

Clinical material provided (Liquid Plasma – 1.2 mL) to assess the qualitative and quantitative detection of Hepatitis B DNA

Frequency / Number of samples

2 surveys / 6 samples per survey

Tests

HBV Qualitative DNA, HBV Quantitative DNA

Molecular Infectious Diseases – Hepatitis C Genotyping

Clinical material provided (Liquid Plasma – 1.2 mL) to assess the genotype of Hepatitis C

Frequency / Number of samples

2 surveys / 6 samples per survey

Tests

Hepatitis C genotyping